Stock ANAB ANAPTYSBIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions AnaptysBio, Inc.

Equities

ANAB

US0327241065

Real-time Estimate Cboe BZX
Other stock markets
 02:40:57 2024-04-26 pm EDT 		5-day change 1st Jan Change
21.1 USD +11.79% Intraday chart for AnaptysBio, Inc. +4.23% -3.31%
Apr. 16 Leerink Partners Starts AnaptysBio With Outperform Rating, $47 Price Target MT
Apr. 11 Wells Fargo Initiates AnaptysBio With Overweight Rating, $56 Price Target MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ANAB Stock
  4. Revisions AnaptysBio, Inc.